|
|
|
Summary Of: Zalcitabine
Zalcitabine appears less potent than some other nucleoside RTIs... Zalcitabine was developed in the National Cancer Institute... Zalcitabine was the third antiretroviral to be approved by the... The sale and distribution of zalcitabine has been discontinued since December 31... Zalcitabine has a very high oral absorption rate of over 80... significantly inhibits the intracellular phosphorylation of zalcitabine to the active form... zalcitabine should not be used with other drugs that can cause peripheral... Resistance to zalcitabine develops infrequently compared with other nRTIs... Encyclodia Page On: Zalcitabine
|
|
 |
